[go: up one dir, main page]

ES554305A0 - Procedimiento para la fabricacion de derivados quinolilglicinamidas - Google Patents

Procedimiento para la fabricacion de derivados quinolilglicinamidas

Info

Publication number
ES554305A0
ES554305A0 ES554305A ES554305A ES554305A0 ES 554305 A0 ES554305 A0 ES 554305A0 ES 554305 A ES554305 A ES 554305A ES 554305 A ES554305 A ES 554305A ES 554305 A0 ES554305 A0 ES 554305A0
Authority
ES
Spain
Prior art keywords
glycinamides
quinolyl
procedure
manufacture
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES554305A
Other languages
English (en)
Other versions
ES8800161A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of ES554305A0 publication Critical patent/ES554305A0/es
Publication of ES8800161A1 publication Critical patent/ES8800161A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES554305A 1985-05-06 1986-04-24 Procedimiento para la fabricacion de derivados quinolilglicinamidas Expired ES8800161A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8507247A FR2581382B1 (fr) 1985-05-06 1985-05-06 Derives n-(quinolyl) glycinamides, leur procede de preparation et leur application therapeutique en tant que psychotropes

Publications (2)

Publication Number Publication Date
ES554305A0 true ES554305A0 (es) 1987-11-16
ES8800161A1 ES8800161A1 (es) 1987-11-16

Family

ID=9319228

Family Applications (1)

Application Number Title Priority Date Filing Date
ES554305A Expired ES8800161A1 (es) 1985-05-06 1986-04-24 Procedimiento para la fabricacion de derivados quinolilglicinamidas

Country Status (16)

Country Link
US (1) US4788188A (es)
EP (1) EP0205362B1 (es)
JP (1) JPH0739395B2 (es)
KR (1) KR860008982A (es)
AT (1) ATE48835T1 (es)
AU (1) AU582235B2 (es)
CA (1) CA1263957A (es)
DE (1) DE3667660D1 (es)
DK (1) DK204686A (es)
ES (1) ES8800161A1 (es)
FR (1) FR2581382B1 (es)
GR (1) GR861169B (es)
IL (1) IL78691A (es)
NZ (1) NZ216048A (es)
PT (1) PT82512B (es)
ZA (1) ZA863382B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610981D0 (en) * 1986-05-06 1986-06-11 Ici America Inc Quinoline amides
GB8610980D0 (en) * 1986-05-06 1986-06-11 Ici America Inc Heterocyclic fused tricyclic compounds
FR2632305B1 (fr) * 1988-06-06 1992-05-15 Sanofi Sa Amino-4 aroyl-3 quinoleines et naphtyridines, leur procede de preparation et leur application en therapeutique
DK273689A (da) * 1988-06-06 1989-12-07 Sanofi Sa 4-amino-3-carboxyquinoliner og -naphthyridiner, fremgangsmaade til deres fremstilling og anvendelse deraf i laegemidler
FR2632861B1 (fr) * 1988-06-15 1990-11-09 Sanofi Sa Derives d'amino-4 carboxy-3 quinoleines et naphtyridines, leur procede de preparation et leur application comme medicaments
FR2632639B1 (fr) * 1988-06-09 1990-10-05 Sanofi Sa Derives d'amino-4 carboxy-3 naphtyridines, leur preparation et compositions pharmaceutiques qui les contiennent
US5493027A (en) * 1993-01-22 1996-02-20 Board Of Regents, The University Of Texas System Anticonvulsive agents and uses thereof
US5783700A (en) * 1997-07-03 1998-07-21 Nichols; Alfred C. Quinolic acid derivatives
DE19960924C2 (de) * 1999-12-17 2002-08-01 Therapeutics Gmbh G.O.T. Amphiphile Polyamine, deren Anwendungen
ATE445838T1 (de) 2001-07-25 2009-10-15 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
CA2789097C (en) 2005-04-28 2017-02-21 Proteus Digital Health, Inc. Pharma-informatics system
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
NZ616673A (en) 2009-02-20 2014-08-29 To Bbb Holding B V Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2456911A (en) * 1945-05-04 1948-12-21 Wyeth Corp Disubstituted acetamidyl derivatives of amino quinolines
US3470186A (en) * 1967-06-02 1969-09-30 American Cyanamid Co Substituted 4-anilino-3-quinolinecarboxylic acids and esters
GB1177548A (en) * 1967-11-28 1970-01-14 Ici Ltd Phenoxy-and Anilino-Alkanoic Acid Amides
FR8491M (es) * 1968-12-31 1973-07-27
US4789678A (en) * 1986-08-25 1988-12-06 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing α-alkyl-4-amino-3-quinolinemethanols and 1-(4-aralkylamino-3-quinolinyl)alkanones and related compounds

Also Published As

Publication number Publication date
ATE48835T1 (de) 1990-01-15
JPS6226271A (ja) 1987-02-04
DK204686A (da) 1986-11-07
NZ216048A (en) 1988-09-29
IL78691A (en) 1989-09-28
JPH0739395B2 (ja) 1995-05-01
FR2581382A1 (fr) 1986-11-07
AU582235B2 (en) 1989-03-16
KR860008982A (ko) 1986-12-19
ZA863382B (en) 1987-01-28
PT82512A (fr) 1986-06-01
AU5714286A (en) 1987-11-12
ES8800161A1 (es) 1987-11-16
DE3667660D1 (de) 1990-01-25
CA1263957A (fr) 1989-12-19
US4788188A (en) 1988-11-29
FR2581382B1 (fr) 1987-06-26
PT82512B (pt) 1988-03-03
GR861169B (en) 1986-09-01
EP0205362A1 (fr) 1986-12-17
EP0205362B1 (fr) 1989-12-20
IL78691A0 (en) 1986-08-31
DK204686D0 (da) 1986-05-02

Similar Documents

Publication Publication Date Title
ES491224A0 (es) Procedimiento para la preparacion de anilidas de acidos 4- amino-2-ureido-(o-tioureido)-pirimidin-5-carboxilicos
ES493011A0 (es) Procedimiento para la preparacion de derivados de pirimi- do-(6,1-a)-isoquinolein-4-onas
ES554305A0 (es) Procedimiento para la fabricacion de derivados quinolilglicinamidas
ES521086A0 (es) Procedimiento para la preparacion de imidazolilfenil-tetrahidropiridazinas.
ES506583A0 (es) Procedimiento para la preparacion de derivados de isoquino- leina
ES513391A0 (es) Procedimiento para la obtencion de 2-aril-3,4-diazabiciclo 4.n.0-alq-2-en-5-onas.
ES549776A0 (es) Procedimiento para la preparacion de pirrolo-bencimidazoles
DK163144C (da) Diethylaminoalkoxybenzhydrolderivater og farmaceutisk acceptable syreadditionssalte og kvaternaere ammoniumsalte deraf, fremgangsmaade til fremstilling heraf, farmaceutisk praeparat og fremgangsmaade til fremstilling heraf
HUT42770A (en) Process for preparing novel pyrrolo-benzimidazole derivatives, pyrrolo -benzoxazole derivatives and pyrrolo-benzthiazole derivatives and pharmaceutical compositions comprising the same
GR861013B (en) Process for the preparation of triazole derivatives
ES2044853T3 (es) Derivados de 1,4-di-hidro-piridina, procedimiento para su fabricacion y medicamentos que contienen estos compuestos.
DE3469527D1 (en) Nortropine derivative, process for its preparation and its use
ES511836A0 (es) "procedimiento para la preparacion de nuevos a1-pirrolin-tiolactimeteres".
ES509154A0 (es) Un procedimiento para la preparacion de nuevos derivados del acido &-glutamil-diaminopimelilo.
ES533688A0 (es) Un procedimiento para preparar un derivado de aminoprpilaminobleomicina

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303